Eloxx Pharmaceuticals Inc. (ELOX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Eloxx Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$13.12
+0.23% today
Market cap
$54M
Overall quality
47/100
Kronos AI 30-day
+28.7%
8 of 8 simulated paths end higher
Eloxx Pharmaceuticals Inc. (ELOX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $54M. It trades at $13.12, up 0.23% today. Its overall quality score is 47 out of 100, ranked against the whole US market. 5 analysts' average target of $37.50 implies +185.8% from today's price. Kronos AI's 30-day forecast is +28.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $37.50 |
| Low – high | $32.00 – $40.00 |
| Analysts | 5 |
| Upside to average | +185.8% |
Kronos AI 30-day forecast
| Expected close | $17.17 (+28.7%) |
| Likely range | +18.4% … +35.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 62 |
| Growth | 28 |
| Overall | 47 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.